Health TrialsbyHealthPanel

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

ConditionAcute Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf

About this trial

This observational study aims to estimate the proportion of patients discharged from a hospital with a prescription for anticoagulant medication who subsequently visit the emergency department due to an adverse thrombotic or hemorrhagic event related to the treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Those who are not part of the CSAPG healthcare area.

Patients discharged from outpatient clinics, home hospitalization units, intermediate care, or residential facilities.

Trial population

Patients who has been discharged from an acute care unit with anticoagulant therapy

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Antithrombotic therapy

    Other intervention

    Anticoagulant treatment prescribed at discharge from an acute care unit

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Anticoagulant therapy1 intervention

Trial outcomes

Primary outcomes

1

Hemorragic event

Proportion of patients who experience a hemorrhagic event within 90 days of hospital discharge

Time frame
Day 90 from baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Consorci Sanitari de l'Alt Penedès i Garraf

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: